Commure Stock for Accredited Investors

Healthcare
By UpMarket Research  |  Last updated: September 2026
CEO Tanay Tandon Founded 2012 HQ Mountain View, US

Commure is an AI-native healthcare technology company that provides enterprise software for revenue cycle management and ambient clinical workflows. It builds tools that automate intake, documentation, coding, claims, and payments for health systems and providers. In May 2026, Commure received a $70 million investment from General Catalyst at a $7 billion post-money valuation (Reuters and Axios).

Access to pre-IPO shares is available to accredited investors through UpMarket.

Last Reported Valuation
$7B
Growth round, 05/19/26, Reuters and Axios
UpMarket Estimate
$7.72B
Based on UpMarket valuation model

How to Invest in Commure Through UpMarket

Commure shares are not on public exchanges. UpMarket provides accredited investors access through secondary market transactions.

Step 01

Verify accredited investor status

Confirm eligibility under SEC Rule 501 of Regulation D. Income or net worth threshold applies.

Step 02

Create an UpMarket account

Complete KYC/AML onboarding. Typically 1–2 business days. Licensed rep assigned on signup.

Step 03

Review available Commure offerings

Full offering memoranda and risk disclosures provided before any commitment is required.

Step 04

Complete subscription documents

Review and sign subscription agreement. All documents handled digitally through the platform.

Step 05

Fund your investment

Wire transfer or ACH. $50K minimum. Funds held in custodial account until close.

Pre-IPO investments are illiquid, speculative, and involve risk of total loss of capital.

${{aum_amount_brokered_en}}B+
UpMarket has brokered over ${{aum_amount_brokered_en}} billion in alternative investments*
*Includes principal invested and appreciation of investments originated via the UpMarket platform based on historical trade volume and valuation estimates through {{aum_as_of_date_en}}. Of the total, approximately ${{aum_amount_managed_en}} million is managed by UpMarket Management, with the remaining originated investments managed by affiliates. Past performance is not predictive of future results.

Valuation Growth Over Time

Post-money valuation by round
Previous rounds Most recent
DateRoundAmount raisedValuation
May 2026 Growth round $70M $7B

Commure's most recent reported round is its Growth round, announced May 19, 2026. It raised $70 million at a reported post-money valuation of $7 billion, led by General Catalyst. Source: Reuters and Axios. Data as of September 27, 2026.

Commure Revenue and Growth

Annual revenue

Why Investors Are Watching Commure

Growth Signal

Commure secures $200M growth financing to meet demand

Commure said it raised $200 million in growth financing from General Catalyst's Customer Value Fund in June 2025. The company said the capital would help meet demand for its revenue cycle management, practice management, and ambient AI offerings.

Product Milestone

Commure expands AI platform across admin and clinical workflow

Commure describes its platform as AI-enabled software for healthcare providers, focused on administrative work and next-generation infrastructure. Its stated product set includes revenue cycle management, practice management, ambient AI clinical documentation, and workflow tools.

Market Opportunity

Commure targets healthcare provider infrastructure at scale

Commure says it powers next-generation infrastructure for providers and works with leading health systems to simplify care delivery. The company also positions its platform as FHIR-compliant, suggesting a broader opportunity across systems, vendors, and startups building healthcare applications.

Interested in Commure stock? Fill out the form above or sign up directly. Subject to availability. Accredited investors only.

Request access →

Commure Leadership Team

Tanay Tandon
CEO

UpMarket Investment Curation Process

  • Full diligence on every offering

    UpMarket curates and conducts independent diligence on every investment opportunity before it reaches the platform.

  • Strategy, fees & legal reviewed in full

    We review every offering's strategy, risk management, liquidity, fees, valuation methodology, tax matters, and all third-party providers: legal counsel, auditor, administrator, and custodian.

  • Disciplined managers only

    We offer investments exclusively from disciplined managers that pursue unique strategies across an array of asset classes.

  • Built around your objectives

    Our goal is to empower you to build a portfolio that best meets your individual investment objectives.

Ready to access institutional-grade private market investments? Unlock private markets

Commure Stock FAQ

No. As of March 2026, Commure is a private company and does not trade on any public stock exchange. Accredited investors can access Commure shares through UpMarket, a FINRA-registered broker-dealer that specializes in pre-IPO investments.

Commure does not have a public stock price because it is privately held. The most recent known share price comes from its last funding round. Pre-IPO share prices on the secondary market may differ from the last round price depending on supply, demand, and market conditions.

Yes. Accredited investors can indicate interest in Commure shares through UpMarket by filling out the form on this page or creating an account at upmarket.co. All pre-IPO offerings are subject to availability and require a $50,000 minimum investment. UpMarket is a FINRA-registered broker-dealer and has brokered alternative investments since 2019.

Pre-IPO investments carry significant risks. Commure shares are illiquid, meaning there is no public market to sell them quickly. There is no guaranteed exit timeline or return. The investment is speculative in nature, and investors should be prepared for the possibility of total loss. Valuations of private companies can fluctuate substantially between funding rounds. Investors should consult their financial advisor and review all offering documents before investing.

In a pre-IPO transaction, accredited investors purchase shares from existing shareholders (such as employees, early investors, or other holders) through secondary market platforms. The company itself does not issue new shares in these transactions. UpMarket facilitates these trades as a FINRA-registered broker-dealer, handling compliance, documentation, and settlement on behalf of both parties.

There are two primary exit paths for pre-IPO holdings: selling your shares on the secondary market to another buyer, or holding until the company completes an IPO or is acquired. Both paths are subject to transfer restrictions, company approval (right of first refusal), and market conditions. The timing of any exit is unpredictable, and investors should plan for a multi-year holding period.

The minimum investment for most pre-IPO offerings on UpMarket is $50,000. This amount may vary depending on the specific offering and share availability. There are no fees to create an UpMarket account or browse available investments. Investors only pay transaction-related fees when they complete an investment.

UpMarket's valuation estimate of $7.72B is derived from a proprietary model that incorporates multiple data sources: funding round data (Caplight), revenue estimates (Sacra), secondary market pricing, and public company comparables. The model applies a private company discount to the public comp multiple to account for illiquidity and information asymmetry. This estimate is not investment advice and may differ substantially from the price at which shares actually trade.

Commure was valued at $7B in its May 2026 Growth round. Accredited investors can request Commure access through UpMarket.

Invest in Commure Request access